ZygoFix has completed a $2 million funding round led by Agriline and Trendlines to advance its innovative screwless spinal fusion implant, zLOCK™, aiming to improve patient outcomes in spinal surgeries.

Target Overview

ZygoFix is a medical technology company focused on developing innovative solutions for spinal fusion. The company has recently introduced its flagship product, zLOCK™, a unique screwless implant designed to offer spinal stability and fusion for patients suffering from severe back pain. The zLOCK™ implant stands out as the least invasive option available, simplifying the traditional procedures that usually involve complex screw stabilization.

With its patented bendable features, the zLOCK™ can be adjusted to accommodate the anatomical shapes of specific joints during insertion, enhancing its effectiveness and ease of use. The implant not only aims to reduce the complexity of spinal surgeries but also aims to improve patient outcomes significantly.

Industry Overview in Israel

The medical technology industry in Israel is renowned for its innovative solutions and cutting-edge research developments. Israel has become a global hotspot for medical device innovation, driven by a combination of high-qua